drugset / Trial / NCT02409004
Effects of Rifampin on the Pharmacokinetics of Ataluren
NaSingle-groupOpen-labelTreatment
Summary
This will be a single centre, Phase I, open-label, one cohort, one dose level, fixed-sequence, drug interaction study in healthy volunteers. The objective of this study is to determine the effects of rifampin on the pharmacokinetics of ataluren under fasting conditions.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ataluren | Small molecule | 1375 mg | Oral |
| Subject | Rifampin | Small molecule | 300 mg | Oral |
Indications
No indication recorded.